Astana Biomed Group, an authorized Abcam distributor in Central Asia

FITC Anti-Podoplanin / gp36 antibody [18H5] (ab205333)

Key features and details

  • FITC Mouse monoclonal [18H5] to Podoplanin / gp36
  • Suitable for: Flow Cyt
  • Reacts with: Human
  • Conjugation: FITC. Ex: 493nm, Em: 528nm
  • Isotype: IgG1

Overview

  • Product name

    FITC Anti-Podoplanin / gp36 antibody [18H5]
    See all Podoplanin / gp36 primary antibodies

  • Description

    FITC Mouse monoclonal [18H5] to Podoplanin / gp36

  • Host species

    Mouse

  • Conjugation

    FITC. Ex: 493nm, Em: 528nm

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    See all applications and species data

  • Immunogen

    Tissue, cells or virus corresponding to Human Podoplanin/ gp36. NP_001006625.1. MDCK cells stably expressing Podoplanin/gp36 protein isoform 6.
    Database link: Q86YL7-6

  • Positive control

    • Primary human dermal lymphatic endothelial cells (HDLEC).

Properties

Images

  • Flow Cytometry - FITC Anti-Podoplanin / gp36 antibody [18H5] (ab205333)
    Flow Cytometry - FITC Anti-Podoplanin / gp36 antibody [18H5] (ab205333)

    Flow cytometric analysis of primary Human dermal lymphatic endothelial cells (HDLEC)  labeling Podoplanin / gp36 with ab205333 at 0.5 µg in 100 µl dilution (lower panel) compared to negative control cells containing no primary antibody (upper panel) or conjugated secondary antibody alone (middle panel). 

  • Flow Cytometry - FITC Anti-Podoplanin / gp36 antibody [18H5] (ab205333)
    Flow Cytometry - FITC Anti-Podoplanin / gp36 antibody [18H5] (ab205333)

    Flow cytometric analysis of primary Human dermal lymphatic endothelial cells (HDLEC) labeling Podoplanin / gp36 with ab205333 at 0.5 µg in 100 µl dilution.  

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to FITC Anti-Podoplanin / gp36 antibody [18H5] (ab205333)

© 2021 Astana Biomed Group LLP. All rights reserved.